| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |